Private Equity

Incline Equity Partners' major investment in workflow automation leader MCCi signals private capital's growing role in modernizing government services.

An $8.75 billion merger was meant to create a building giant. Instead, a 35% stock crash has sparked a securities investigation into James Hardie.

The Don Pepino owner is buying the organic tomato brand from General Mills, a strategic move set to reshape the competitive $5 billion tomato products aisle.

Veteran leader Emma Rooth takes charge at PCCA UK, bringing a track record of transformation to the booming personalized medicine market.

Activist investor Farallon Capital pressures insurer T&D Holdings with a public blueprint for reform, demanding bold changes ahead of its 2026 vision.

Haffner Energy launches its C-iC modular line, aiming to slash project costs and make mid-sized biofuel and hydrogen production financially viable without subsidies.

As China's EV boom accelerates, a State Grid subsidiary in Gansu inspects rural charging piles, ensuring safety and reliability for a growing user base.

A French biotech is advancing a novel class of drugs that don't just fight cravings but may reverse the deep-seated brain changes caused by addiction.

With over $2B in acquisitions and $1B in new projects, Clarion is aggressively reshaping its portfolio. Is industrial real estate the ultimate safe haven?

A strategic investment from Krieger Capital will fuel Global Key Solutions' AI platform, which transforms complex regulatory data into actionable safety insights.

New AI agent allows VCs and PE firms to analyze entire portfolios with natural language, promising to eliminate manual data work and speed up decisions.

With a top PE award and a 'founder-friendly' nod, Banner Capital's focus on Main Street businesses in the West signals a new path to success.

Facing a legacy of recalls from its predecessor, medical device firm Advita Ortho launches a new quality initiative. Is it a true turnaround?

Grady Campbell's annual list is out, but what makes a top firm? We explore the criteria, the industry impact, and the business of recognition.

The acquisition strengthens the independent distributor's hold on the booming plasma therapy market, promising wider access to critical, complex medications.

The nation's largest independent union elevator firm merges with a Bay Area leader, signaling a major consolidation in a critical infrastructure market.

As human capital becomes a key value driver, L.Maxwell Global brings on a veteran CPO to guide CEOs, boards, and private equity through market complexity.

With gold prices soaring past $5,000, one junior miner is betting on a vertically integrated model to turn record highs into major profits.

Baird Medical partners with Stonewood Key Capital, using China's Hainan Free Trade Port to accelerate its global push for minimally invasive therapies.

Leios Therapeutics partners with BNC Korea, securing a key investment and pathway to Asia's lucrative body contouring market for its 10XB-101 injectable.